Why the study?
Does insulin treatment improve axonal excitability in diabetic patients?
Does insulin treatment improve axonal excitability in diabetic patients?
Glycemic control with insulin rapidly alters nerve excitability in diabetic patients, likely reflecting changes in metabolic factors such as Na+/K+ pump activity.
Answers are grounded in this paper and cite their sources.
Insulin may rapidly alter nerve excitability in diabetes; hypothesis-generating and requires randomized confirmation before practice change.
OBJECTIVE: To investigate whether glycemic control is associated with reversible changes in axonal excitability in human diabetic nerves. It is known that voluntary contraction or compression ischemia alters nerve Na+/K+ pump activity, and axonal excitability changes due to the pump activity can be estimated by threshold tracking. METHODS: Threshold, the current required to produce a compound muscle action potential 50% of maximum, was determined from the stimulus-response curve, and threshold changes produced by maximal voluntary contraction or ischemia were measured before and after insulin treatment in 10 diabetic patients. RESULTS: Within 3 weeks of the start of treatment, the threshold changes became greater following voluntary contractions (+13+/-4% versus +23+/-5%; mean+/-SEM; p=0.04) and during ischemia (-5+/-2% versus -11+/-2%; p=0.04). CONCLUSIONS: The extent of threshold fluctuation depends on multiple metabolic factors associated with diabetes such as decreased Na+/K+ ATPase activity, increased anaerobic glycolysis, and tissue acidosis, and nerve excitability can respond quickly to glycemic control in diabetic patients.
No takes yet. Share an insight, caveat, or question.
Kuwabara et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: